Volume | 373,108 |
|
|||||
Noticias | - | ||||||
Máximo del Dia | 0.2792 | Mínimo Máximo |
|||||
Minimo del Dia | 0.2505 |
Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Theriva Biologics Inc | TOVX | AMEX | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
0.261 | 0.2505 | 0.2792 | 0.2501 | 0.2673 |
Operaciones | Volume Operado de la Acción | Precio Promedio Ponderado | Volume Financiero | Volumen promedio | Rango 52 semanas |
---|---|---|---|---|---|
991 | 373,108 | US$ 0.2620575 | US$ 97,776 | - | 0.1972 - 1.20 |
Último Operado | Tipo de Operación | Cantidad Operada | Precio Operado | Divisa |
---|---|---|---|---|
19:00:00 | 1,507 | US$ 0.2501 | USD |
Información Financiera Theriva Biologics Inc TOVX
Capitalización de Mercado [m] | Acciones en circulación | Float | Ingresos | Ganancia/Pérdida | Utilidad por Acción (UPA) | Ratio Precio/Utilidad |
---|---|---|---|---|---|---|
4.26M | 17.04M | - | 0 | -18.35M | -1.08 | - |
Interés de corto | Dividendos Por Acción | Rendimiento del Dividendo | Fecha esperada de dividendos | Transacciones ejecutivas | % de acciones controladas por todos los ejecutivos y 5% propietarios: |
---|---|---|---|---|---|
- | - | - | - |
Noticias sobre Theriva Biologics Inc TOVX
Fecha | Hora | Fuente | Noticias Artículo |
---|---|---|---|
23/5/2024 | 07:20 | Edgar (US Regulatory) | Form 8-K - Current report |
16/5/2024 | 06:30 | Edgar (US Regulatory) | Form 8-K - Current report |
07/5/2024 | 06:10 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
07/5/2024 | 06:05 | Edgar (US Regulatory) | Form 8-K - Current report |
07/2/2024 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
08/1/2024 | 07:10 | Edgar (US Regulatory) | Form 8-K - Current report |
15/12/2023 | 15:07 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/12/2023 | 15:01 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/12/2023 | 15:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
15/12/2023 | 15:00 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
13/11/2023 | 07:15 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
23/10/2023 | 06:10 | Edgar (US Regulatory) | Form 8-K - Current report |
Histórico de Datos TOVX
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 0.3389 | 0.3389 | 0.241 | 0.2927209 | 1,281,570 | -0.0783 | -23.10% |
1 Month | 0.4214 | 0.4911 | 0.241 | 0.3288336 | 1,494,412 | -0.1608 | -38.16% |
3 Months | 0.455 | 0.6845 | 0.241 | 0.3601346 | 613,336 | -0.1944 | -42.73% |
6 Months | 0.59 | 0.6845 | 0.241 | 0.3732806 | 317,979 | -0.3294 | -55.83% |
1 Year | 0.7099 | 1.20 | 0.1972 | 0.6537132 | 353,990 | -0.4493 | -63.29% |
3 Years | 0.80 | 1.26 | 0.1972 | 0.6635813 | 240,905 | -0.5394 | -67.43% |
5 Years | 0.80 | 1.26 | 0.1972 | 0.6635813 | 240,905 | -0.5394 | -67.43% |